This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
The partnership will enable rapid and reliable product delivery
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The observations are procedural in nature and will be responded to within the stipulated time
OncoMate MSI Dx Analysis System is a PCR-based assay designed to evaluate MSI status in tumor tissue
Subscribe To Our Newsletter & Stay Updated
